These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5923750)

  • 21. [Comparative studies on monoamine oxidase inhibitors].
    Matthies H; Lietz W; Fähse C; Pohle W; Popov N; Grade K
    Acta Biol Med Ger; 1966; 17(5):614-36. PubMed ID: 5991587
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of catecholamines, adrenergic substances and their blocking agents on the searching behavior of mice.
    Fischer E; Saavedra JM; Heller B
    Arzneimittelforschung; 1968 Jul; 18(7):780-6. PubMed ID: 5755819
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticonvulsant properties of some newer monoamine oxidase inhibitors.
    Kohli RP; Gupta TK; Parmar SS; Arora RC
    Jpn J Pharmacol; 1967 Sep; 17(3):409-15. PubMed ID: 5300187
    [No Abstract]   [Full Text] [Related]  

  • 24. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 25. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.
    Robson RD
    Circ Res; 1971 Jun; 28(6):662-70. PubMed ID: 4325846
    [No Abstract]   [Full Text] [Related]  

  • 26. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological studies on the brain mechanisms underlying two forms of behavioral excitation: stereotyped hyperactivity and "rage".
    Randrup A; Munkvad I
    Ann N Y Acad Sci; 1969 Jul; 159(3):928-38. PubMed ID: 4902868
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influence of various drugs on liver glycogen and blood sugar levels in reserpinized rats. Combined effect of MAOI, 5HTP, DOPA, ACTH and cortisone].
    Kobayashi M; Nino T; Mori T; Fukuyo S; Yazawa T
    Nihon Yakurigaku Zasshi; 1971; 67(3):265-73. PubMed ID: 4326925
    [No Abstract]   [Full Text] [Related]  

  • 30. The hypothermic effect of L-dopa in the rat.
    Maj J; Pawlowksi L
    Life Sci; 1973 Jul; 13(2):141-9. PubMed ID: 4270866
    [No Abstract]   [Full Text] [Related]  

  • 31. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 32. The respective involvement of noradrenaline and its deaminated metabolites in waking and paradoxical sleep: a neuropharmacological model.
    Jones B
    Brain Res; 1972 Apr; 39(1):121-36. PubMed ID: 4402049
    [No Abstract]   [Full Text] [Related]  

  • 33. [Does potentiation of the excito-motor effects of tryptamine in the rat and mouse enable one to measure the action of monoamine oxidase inhibitors?].
    Denys A; Levy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):457-74. PubMed ID: 5850025
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct evidence for a centrally-mediated hypotensive action of L-dopa in anesthetized dogs.
    Kaplan HR; Barker JW; La Sala SA
    Eur J Pharmacol; 1972 Feb; 17(2):273-8. PubMed ID: 4402097
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolism of dihydroxyphenylalanine in man before and after administration of psychotropic drugs.
    FRIEND DG
    Ann N Y Acad Sci; 1962 Jan; 96():152-9. PubMed ID: 13895327
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain serotonin metabolism in lithium treated rats.
    Segawa T; Nakano M
    Jpn J Pharmacol; 1974 Apr; 24(2):319-24. PubMed ID: 4546737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.